Status: Not yet recruiting
A Trial of HRS-1780 in Participants With Uncontrolled Hypertension or Resistant Hypertension.
The study is being conducted to evaluate the efficacy and safety of HRS-1780 in participants with uncontrolled hypertension or resistant hypertension. To explore the optimal use of HRS-1780 in participants with uncontrolled hypertension or resistant hypertension。
Participants needed: 914
Trial details
Phase: Phase 2, Phase 3Age: 18-80Biological sex: AllType: InterventionalSponsor: Shandong Suncadia Medicine Co., Ltd.Updated: Jul 16, 2026Locations: 2
Eligibility criteria
Male or female, aged ≥ 18 and < 80 years ； [+6]
Mean trough seated DBP ≥ 110 mmHg at randomization. [+28]